Dehydration News and Research

Latest Dehydration News and Research

Study examines complications in adult tonsillectomies and impact on health care expenditures

A study released today of 36,210 adult tonsillectomy patients finds that 20 percent will have a complication, offering valuable new insights to a decades long discussion. The study, featured in the April 2014 issue of Otolaryngology-Head and Neck Surgery, examines the prevalence of complications in adult tonsillectomies and the impact on health care expenditures.

2 Apr 2014

Risk of preterm births is 27% higher during high temperatures

When temperatures reach 32°C or higher over a period of four to seven days, the risk of early-term delivery is 27% higher than on typical summer days, according to a study led by Nathalie Auger of the University of Montreal's Department of Social and Preventive Medicine.

1 Apr 2014

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Gastric bypass and sleeve gastrectomy - two of the most commonly used bariatric surgeries - are more effective than intensive medical therapy alone when it comes to managing uncontrolled type 2 diabetes in overweight or obese patients after three years, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.

1 Apr 2014

Extreme summer heat in Montreal may have effect on early-term deliveries

When temperatures reach 32-C or higher over a period of four to seven days, the risk of early-term delivery is 27% higher than on typical summer days, according to a study led by Nathalie Auger of the University of Montreal's Department of Social and Preventive Medicine. The study involved data from 300,000 births that took place in Montreal between 1981 to 2010 with summer temperatures recorded by Environment Canada during this period. Auger is also affiliated with the university's CHUM Superhospital Research Centre.

1 Apr 2014

Study finds significant reduction in hospital admissions with Medicare Part D prescription coverage

A new study by the Johns Hopkins Bloomberg School of Public Health and the University of Illinois at Chicago finds that Medicare Part D prescription coverage significantly reduced hospital admissions and program expenditures totaling $1.5 billion annually.

4 Mar 2014

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Pharmacyclics, Inc. today reported financial results and recent developments for the quarter and year ended December 31, 2013.

20 Feb 2014

Researchers develop rehydration beverage to treat hypohydration in astronauts

How is living in space like playing in the Super Bowl? Both involve circumstances that cause the body to involuntarily lose water. Astronauts and athletes with low body water can suffer physical performance impairments and can develop symptoms such as headaches, fatigue, muscle cramps, light headedness, disorientation and, in severe cases, loss of consciousness.

4 Feb 2014

Diabetic British Muslims may avoid attending GP surgeries to discuss fasting during Ramadan

British Muslims with diabetes may avoid attending GP surgeries to discuss fasting during the holy month of Ramadan - with potentially serious consequences for their future health, new research by the universities of Manchester and Keele shows.

From The University of Manchester 24 Jan 2014

Dermatologist provides tips to keep skin and hair in prime condition during winter

Winter time woes extend beyond cold temperatures and sometimes gloomy weather. Your skin can react negatively to the constant temperature changes as you move indoor to outdoor for daily living activities.

16 Jan 2014

Study questions widely used method of diagnosing acute mountain sickness

A study led by University of British Columbia scientists calls into question a widely used method of diagnosing acute mountain sickness.

9 Jan 2014

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma (melanoma that cannot be removed by surgery) or metastatic melanoma (melanoma which has spread to other parts of the body) with BRAF V600E or V600K mutations.

9 Jan 2014

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Commission has granted approval for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas, or metastatic pancreatic cancer.

7 Jan 2014

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.

3 Jan 2014

Taking simple steps to stay healthy while traveling can make holidays more enjoyable, says expert

Traveling long distances during the holidays -- whether by car, plane or train -- is a common custom for many Americans, but taking health precautions for the journey isn't often at the top of to-do lists. Taking some simple steps to stay healthy while traveling can make the holidays more enjoyable and safe, according to a Mayo Clinic expert.

17 Dec 2013

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Janssen Research & Development, LLC (Janssen) today announced it has received from the U.S. Food and Drug Administration (FDA) a complete response letter regarding its New Drug Application (NDA) for a fixed-dose combination (FDC) of canagliflozin and immediate-release metformin to treat adults with type 2 diabetes.

16 Dec 2013

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Novartis will present updates on its broad cancer portfolio with more than 240 abstracts at the upcoming American Society of Hematology (ASH) annual meeting and CTRC-AACR San Antonio Breast Cancer Symposium (SABCS).

4 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

San Diego School of Medicine receives grant to provide professional training to senior drivers

For the seventh consecutive year, the Training, Research and Education for Driving Safety (TREDS) program at the University of California, San Diego School of Medicine has been awarded a grant from the California Office of Traffic Safety (OTS) that will help keep our roadways and senior drivers safe through professional training.

27 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

NovaBay Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing topical non-antibiotic antimicrobial products, today announced the publication of a scientific paper by Dr. John R. Crew of Seton Medical Center, Daly City, California, describing the first use of adjunctive NeutroPhase irrigation therapy in conjunction with Negative Pressure Wound Therapy to successfully manage the severely-infected wound in the arm of a patient with life-threatening 'flesh-eating' disease.

20 Nov 2013

Dehydration News and Research

Latest Dehydration News and Research

Study examines complications in adult tonsillectomies and impact on health care expenditures

Risk of preterm births is 27% higher during high temperatures

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Extreme summer heat in Montreal may have effect on early-term deliveries

Study finds significant reduction in hospital admissions with Medicare Part D prescription coverage

Pharmacyclics total revenue for fourth quarter 2013 increases 113% to $123.6 million

Researchers develop rehydration beverage to treat hypohydration in astronauts

Diabetic British Muslims may avoid attending GP surgeries to discuss fasting during Ramadan

Dermatologist provides tips to keep skin and hair in prime condition during winter

Study questions widely used method of diagnosing acute mountain sickness

GSK receives FDA approval for combination of Mekinist with Tafinlar for treatment of melanoma

EC grants approval for ABRAXANE in combination with gemcitabine for metastatic pancreatic cancer

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Taking simple steps to stay healthy while traveling can make holidays more enjoyable, says expert

Janssen receives complete response letter for canagliflozin/metformin FDC therapy for type 2 diabetes

Novartis to present updates on broad cancer portfolio at ASH and SABCS symposiums

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

San Diego School of Medicine receives grant to provide professional training to senior drivers

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

NeutroPhase irrigation therapy and NPWT help treat severe flesh eating and wound infections

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Dehydration News and Research

Latest Dehydration News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in